Insider · CIK 0001836816

Ullman Anders

Reports to the SEC for 1 company · LONDON, X0

sec.gov

Transactions

Companies

Filings

CIK

0001836816

Forms 4 and 5

Insider transactions

17 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2025-10-07	VRNAVerona Pharma plcD Disposition to Issuer	Director	DDisposition to Issuer	−359K sh	—	—	0
2025-10-07	VRNAVerona Pharma plcM Exercise/Conversion	Director	MExercise/Conversion	+72K sh	—	—	72,000
2025-10-07	VRNAVerona Pharma plcD Disposition to Issuer	Director	DDisposition to Issuer	−72K sh	—	—	0
2025-10-07	VRNAVerona Pharma plc · Restricted Share UnitM Exercise/Conversion	Director	MExercise/Conversion	−72K sh	—	—	0
2025-10-07	VRNAVerona Pharma plc · Share Options (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−200K sh	—	—	0
2025-10-07	VRNAVerona Pharma plc · Share Options (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−96K sh	—	—	0
2025-10-07	VRNAVerona Pharma plc · Share Options (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−240K sh	—	—	0
2025-10-07	VRNAVerona Pharma plc · Share Options (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−64K sh	—	—	0
2025-08-01	VRNAVerona Pharma plcM Exercise/Conversion	Director	MExercise/Conversion	+24K sh	—	—	358,856
2025-08-01	VRNAVerona Pharma plc · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−24K sh	—	—	72,000
2025-04-25	VRNAVerona Pharma plc · Restricted Share UnitsA Award	Director	AAward	+96K sh	—	—	96,000
2024-04-29	VRNAVerona Pharma plc · Share Options (Right to Buy)A Award	Director	AAward	+240K sh	—	—	240,000
2023-04-28	VRNAVerona Pharma plc · Share Options (Right to Buy)A Award	Director	AAward	+96K sh	—	—	96,000
2022-04-28	VRNAVerona Pharma plc · Share Options (Right to Buy)A Award	Director	AAward	+200K sh	—	—	200,000
2021-08-09	VRNAVerona Pharma plc · Share Options (Right to Buy)A Award	Director	AAward	+64K sh	—	—	64,000
2021-05-04	VRNAVerona Pharma plcS Sale	Director	SSale	−12.1K sh	$0.84	−$10.1K	334,856
2021-02-01	VRNAVerona Pharma plcS Sale	Director	SSale	−10.8K sh	$0.99	−$10.7K	346,912

Recent filings

Accepted (ET)
Oct 84
Ullman Anders0001104659-25-097959
SEC(opens sec.gov)
Aug 54
Ullman Anders0001104659-25-074380
SEC(opens sec.gov)
Apr 294
Ullman Anders0001104659-25-041404
SEC(opens sec.gov)
Apr 304
Ullman Anders0001104659-24-054954
SEC(opens sec.gov)
Apr 284
Ullman Anders0001104659-23-053022
SEC(opens sec.gov)
Apr 294
Ullman Anders0001104659-22-053704
SEC(opens sec.gov)
Aug 104
Ullman Anders0001104659-21-102886
SEC(opens sec.gov)
May 54
Ullman Anders0001104659-21-061812
SEC(opens sec.gov)
Feb 34
Ullman Anders0001104659-21-011750
SEC(opens sec.gov)

Companies

Verona Pharma plcDirectorVRNA

Address

3 MORE LONDON RIVERSIDE

LONDON, X0, SE1 2RE